(S1 (S (S (NP (NP (JJ Collagen-poly) (JJ glycolic) (NN acid) (NN hybrid) (NN matrix)) (PP (IN with) (NP (JJ basic) (NN fibroblast) (NN growth) (NN factor)))) (VP (VBD accelerated) (NP (NP (NN angiogenesis)) (CC and) (NP (NN granulation) (NN tissue) (NN formation))) (PP (IN in) (NP (JJ diabetic) (NNS mice))))) (. .)))
(S1 (S (S (SBAR (IN Because) (S (NP (NP (JJ poor) (NN skin) (NN wound) (NN healing)) (VP (VBN associated) (PP (IN with) (NP (NNS diabetes))))) (VP (VBZ is) (VP (VBN thought) (S (VP (TO to) (VP (VB be) (ADVP (RB partly)) (NP (NP (DT a) (NN result)) (PP (IN from) (NP (JJ impaired) (NN angiogenesis))))))))))) (, ,) (NP (NP (NNS treatments)) (SBAR (WHNP (WDT that)) (S (VP (VB improve) (NP (NN angiogenesis)))))) (VP (MD could) (VP (VB have) (NP (JJ important) (JJ clinical) (NNS applications))))) (. .)))
(S1 (S (NP (PRP We)) (ADVP (RB herein)) (VP (VBP report) (NP (NP (NP (DT the) (NNS effects)) (PP (IN of) (NP (JJ novel) (VBN developed) (NN material)))) (, ,) (NP (NP (NP (JJ collagen-poly) (JJ glycolic) (NN acid)) (NN fiber) (NN hybrid) (NN matrix)) (, ,) (VP (VBG being) (VP (VBN used) (PP (ADVP (RB together)) (IN with) (NP (NP (JJ basic) (NN fibroblast) (NN growth) (NN factor)) (S (VP (TO to) (VP (VB promote) (NP (NP (NN wound) (NN healing)) (PP (IN of) (NP (JJ full-thickness) (NN skin) (NNS defects))) (PP (IN on) (NP (NP (DT the) (RB back)) (PP (IN of) (NP (ADJP (NN type) (CD 2) (JJ diabetic)) (JJ Lepr-LRB-db-RRB-) (NNS mice)))))))))))))))) (. .)))
(S1 (S (S (NP (PRP$ Our) (NN data)) (VP (VBZ indicates) (SBAR (IN that) (S (NP (DT this) (JJ therapeutic) (NN approach)) (ADVP (RB markedly)) (VP (VBZ promotes) (NP (NP (NN angiogenesis)) (CC and) (NP (NN granulation) (NN tissue) (NN formation))) (PP (IN in) (NP (NP (NN comparison)) (PP (IN with) (NP (NP (JJ other) (NNS conditions)) (PP (NP (CD 14) (NNS days)) (IN after) (NP (NN wounding)))))))))))) (. .)))
